Kopran Share Price

Kopran Share Price

NSE: KOPRAN
|
Pharmaceuticals
|
S Cap
₹ 276.44
-₹6.54 (-2.31%)
1D
Last updated 22 Sep, 2026, 15:58 IST

Kopran Share Price Today

As of 23 Sep 2026, Kopran share price is ₹276.44. The stock opened at ₹282.90, compared to its previous close of ₹282.98. During today's trading session, Kopran share price moved in the range of ₹270.00 to ₹285.49, with an average price of ₹277.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹107.00 and a high of ₹286.53. On the performance front, Kopran share price has increased by 133.84% over the last six months and is up 59.75% on a year-on-year basis.

₹270.00
2.31% down today
₹285.49
1D LOW
1D HIGH

Kopran Returns Calculator

Circuit
L
H
₹221.16
₹331.72
52-week
L
H
₹107.00
₹286.53

About Kopran

Kopran Share Price
ISIN
INE082A01010
Sector Market Cap
₹ 1,367.87 Cr

Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.

Kopran Financial Highlights

  • Revenue: Kopran reported revenue of ₹681.77 crore in FY26 vs ₹633.58 crore in FY25. It showed an increase of 7.61% on a yearly basis.
  • Operating Profit: Kopran reported an operating profit of ₹34.36 crore in FY26 vs ₹51.95 crore in FY25. It showed a decrease of 33.86% on a year-on-year basis.
  • Net Profit: Kopran reported a net profit of ₹25.73 crore in FY26 vs ₹38.55 crore in FY25. It showed a decrease of 33.26% on a yearly basis.

Kopran Quarterly Result Highlights

  • Kopran reported revenue of ₹156.04 crore in Jun 2026, compared with ₹234.11 crore in Mar 2026, representing a decrease of 33.35% on a quarter-on-quarter (QoQ) basis.
  • Kopran reported an operating profit of ₹8.80 crore in Jun 2026, compared with ₹25.35 crore in Mar 2026, representing a decrease of 65.29% on a quarter-on-quarter (QoQ) basis.
  • Kopran reported a profit of ₹6.70 crore in Jun 2026, compared with ₹18.87 crore in Mar 2026, reflecting a decrease of 64.49% on a QoQ basis.
  • The earnings per share (EPS) of Kopran stood at ₹5.33 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
44.42%
FII
0.51%
Other DII
0.00%
Retail and other
55.06%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.60%
Dec 20250.36%
Mar 20260.57%
Jun 20260.51%
Mkt Cap Cr
1,337.42
P/E
53.53
P/B
2.52
ROE
4.85%
D/E
0.10
ROCE
6.56%
Div. Yield
1.06%
EPS(TTM)
6.30
Turnover
0.52
EV/EBITDA
23.83
Net Margin
9.95%
Op. Margin
16.22%
ROA
2.75%
Quick Ratio
1.19
Curr. Ratio
2.32
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Kopran outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Kopran appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Kopran earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Kopran Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹681.42₹629.60₹614.59₹550.99
Other Income₹0.35₹3.98₹14.61₹3.07
Total Revenue₹681.77₹633.59₹629.20₹554.05
Total Expenses₹647.41₹581.64₹561.66₹517.99
Profit Before Tax₹34.36₹51.95₹67.54₹36.07
Tax₹8.63₹13.40₹16.59₹8.83
Profit After Tax₹25.73₹38.55₹50.96₹27.23
EPS - Basic₹5.33₹7.99₹10.57₹5.65
EPS - Diluted₹5.33₹7.99₹10.57₹5.65

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹51.95₹67.54₹36.07₹81.78
Income before WC changes₹76.75₹88.50₹52.36₹95.60
Change in Assets-₹39.13-₹37.47-₹73.13-₹89.48
Change in Liabilities₹17.57₹6.55₹67.58-₹21.33
Change in WC-₹21.56-₹30.91-₹5.55-₹110.81
Cash flow from Operations₹41.94₹43.26₹34.02-₹33.48
Cash flow from Investing-₹56.43-₹43.55-₹12.65-₹84.42
Cash flow from Financing₹25.87₹0.99-₹19.84₹122.82
Total Cash Flow₹11.38₹0.69₹1.53₹4.93
Cash (Start of the year)₹8.09₹7.40₹5.87₹0.94
Cash (End of the year)₹19.47₹8.09₹7.40₹5.87

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹385.19₹334.26₹289.22₹250.63
Current Assets₹523.18₹509.75₹454.03₹399.07
Total Assets₹908.36₹844.01₹743.25₹649.70
Current Liabilities₹346.18₹288.97₹218.53₹176.97
Net Current Asset₹177.00₹220.78₹235.50₹222.10
Non-Current Liabilities₹31.90₹36.70₹33.47₹33.48
Equity Capital₹530.28₹518.35₹491.25₹439.25
Total Equity & Liabilities₹908.36₹844.01₹743.25₹649.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹305.65₹271.01₹337.46₹273.09
Other Income₹2.00₹5.90₹16.71₹16.09
Total Revenue₹307.65₹276.91₹354.17₹289.18
Total Expenses₹267.25₹241.12₹309.65₹252.27
Profit Before Tax₹40.39₹35.79₹44.52₹36.92
Tax₹9.99₹8.94₹9.88₹5.66
Profit After Tax₹30.40₹26.86₹34.64₹31.25
EPS - Basic₹6.30₹5.57₹7.18₹6.48
EPS - Diluted₹6.30₹5.57₹7.17₹6.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹35.79₹44.52₹36.92₹16.16
Income before WC changes₹42.38₹47.20₹27.87₹20.33
Change in Assets-₹5.26₹8.36-₹39.24-₹41.63
Change in Liabilities-₹3.73-₹10.77₹34.55-₹12.90
Change in WC-₹8.99-₹2.41-₹4.68-₹54.53
Cash flow from Operations₹23.30₹34.96₹16.87-₹37.80
Cash flow from Investing-₹15.41-₹6.27₹10.05-₹100.26
Cash flow from Financing₹5.64-₹24.08-₹26.13₹137.99
Total Cash Flow₹13.53₹4.61₹0.79-₹0.07
Cash (Start of the year)₹5.65₹1.04₹0.25₹0.32
Cash (End of the year)₹19.18₹5.65₹1.04₹0.25

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹365.65₹337.44₹323.17₹315.54
Current Assets₹240.24₹209.05₹187.70₹190.41
Total Assets₹605.89₹546.48₹510.88₹505.95
Current Liabilities₹146.94₹103.33₹84.54₹100.88
Net Current Asset₹93.29₹105.72₹103.16₹89.53
Non-Current Liabilities₹11.12₹11.72₹9.47₹9.48
Equity Capital₹447.83₹431.44₹416.87₹395.59
Total Equity & Liabilities₹605.89₹546.48₹510.88₹505.95
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
276.44
322
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 322
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
3
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
75.91
Bullish
ATR (14)
16.84
Neutral
STOCH(9,6)
83.28
Bearish
STOCH RSI (14)
60.08
Neutral
ADX(9)
56.62
Bearish
UO(9)
59.99
Neutral
ROC(12)
19.03
Bullish
WillR(14)
-13.92
Bearish
Period
Simple value
Exponential vaue
5D
273.29
271.44
10D
256.13
259.48
20D
235.39
242.23
50D
210.88
218.13
100D
195.95
198.94
Volume trend — traded volume by day
22 Sep6L
21 Sep12L
18 Sep24L
17 Sep31L
16 Sep1Cr
Average43L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Kopran Share Price
Kopran
Pharmaceuticals
Add Stock
Add Another

Kopran Share Price FAQs

Kopran share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837